Toggle main navigation
News
Insights
Meetings
Multimedia
ASCO AI in Oncology
Search
Close
AI in Oncology
Bladder Cancer
Breast Cancer
Cardio-oncology
CNS Cancers
Colorectal Cancer
Cost of Care
Infectious Diseases
Gastrointestinal Cancer
Genomics/Genetics
Geriatric Oncology
Global Cancer Care
Gynecologic Cancers
Head and Neck Cancer
Health-Care Policy
Hepatobiliary Cancer
Immunotherapy
Kidney Cancer
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Neuroendocrine Tumors
Pancreatic Cancer
Prostate Cancer
Sarcoma
Skin Cancer
Survivorship
Thyroid Cancer
Solid Tumors
Hematologic Malignancies
Issues in Oncology
Genitourinary Cancer
Advertisement
The ASCO Post
Genitourinary Cancer
Genitourinary Cancer
Germline Testing Remains Low Among Patients With Upper Tract Urothelial Carcinoma
November 18
3 min read
Investigators identified substantial gaps in germline genetic testing among patients with upper tract urothelial carcinoma, including those meeting established criteria for genetic evaluation.
Latest in Genitourinary Cancer
Load More
Advertisement